Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

8

Revenue 2017

40

Revenue 2017

Enbrel

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Enbrel was produced by Amgen, Takeda and Pfizer.

Amgen CEO says Aimovig is “one of most successful launches”

Amgen CEO says Aimovig is “one of most successful launches”

TNF inhibitor Enbrel (etanercept) also fell 5% in the face of competition from newer drugs in indications such as psoriasis.

Amgen’s R&D chief Sean Harper retires to seek biotech post

Amgen’s R&D chief Sean Harper retires to seek biotech post 1bn – around $400m ahead of forecasts – with newer products helping to offset an 11% decline in Amgen’s top-seller Enbrel (etanercept) to $1.3bn, affected by competition for TNF inhibitors

Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS

Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS III candidate upadacitinib - analysts predict these drugs will seize share from older drugs such as Amgen/Pfizer’s Enbrel.

Sun Pharma passes milestone with novel psoriasis drug approval

Sun Pharma passes milestone with novel psoriasis drug approval inhibitor Enbrel (etanercept), a widely-used biologic for the skin condition. ... For years treatment for patients requiring systemic therapy has been dominated by TNF blockers such as Enbrel and AbbVie’s Humira (adalimumab), but these are now expected

The good, the bad and the ugly

The good, the bad and the ugly These declines are driven by the patent expiry of Enbrel and subsequent brand erosion caused by the launch of biosimilars,” says Annis. ... Sanofi’s Lantus (-18.8%), Amgen’s Enbrel (-10.8%) and Gilead’s Harvoni (-48.5%) are among those whose

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics